Empowering patients from within: Emerging nanomedicines for in vivo immune cell reprogramming.
Empowering patients from within: Emerging nanomedicines for in vivo immune cell reprogramming.
复制标题
DOI:
10.1016/j.smim.2021.101537
复制
发表时间:
2021-08
影响因子:
7.8
通讯作者:
Stephan MT
中科院分区:
文献类型:
--
作者:
Stephan MT
Currently, medicine lacks the ability to reprogram selected immune cells so they possess all the functions which, from a clinical standpoint, physicians might wish them to have. To solve this problem, scientists have been marrying concepts from materials science, immunology, and genetic engineering to develop novel nanotherapeutics that directly genetically reprogram immune cells inside the body. These products could address key limitations of existing ex vivo-engineered cell immunotherapies and substantially enhance patient access and outcomes. This review highlights the latest advances in this rapidly emerging biotech field and discusses challenges in translating these preclinical studies into successful clinical nanomedicines.
登录
查看更多内容
影响因子:
46.9
作者:
Judge, AD;Sood, V;MacLachlan, I
通讯作者:
MacLachlan, I
影响因子:
14
作者:
Jain, Shardool;Thanh-Huyen Tran;Amiji, Mansoor
通讯作者:
Amiji, Mansoor
影响因子:
46.9
作者:
Klichinsky M;Ruella M;Shestova O;Lu XM;Best A;Zeeman M;Schmierer M;Gabrusiewicz K;Anderson NR;Petty NE;Cummins KD;Shen F;Shan X;Veliz K;Blouch K;Yashiro-Ohtani Y;Kenderian SS;Kim MY;O'Connor RS;Wallace SR;Kozlowski MS;Marchione DM;Shestov M;Garcia BA;June CH;Gill S
通讯作者:
Gill S
DOI:
10.1146/annurev-bioeng-071813-105259
发表时间:
2014-07-11
影响因子:
9.7
作者:
Jain RK;Martin JD;Stylianopoulos T
通讯作者:
Stylianopoulos T
DOI:
10.1016/j.omtm.2020.12.008
发表时间:
2021-03-12
期刊:
Molecular therapy. Methods & clinical development
影响因子:
--
作者:
Alzubi J;Lock D;Rhiel M;Schmitz S;Wild S;Mussolino C;Hildenbeutel M;Brandes C;Rositzka J;Lennartz S;Haas SA;Chmielewski KO;Schaser T;Kaiser A;Cathomen T;Cornu TI
通讯作者:
Cornu TI